Kombiglyze XR
Kombiglyze XR is a diabetes medication containing Saxagliptin + Metformin, available as 5/500/5/1000mg tablets.
- Category
- Diabetes
- Active ingredient
- Saxagliptin · Metformin
- Route
- Oral use
- Form
- Prolonged-release tablet
- Strengths
- 5/500/5/1000mg
Prescription rules on Kombiglyze XR vary by country.
Details
- Conditions
- Type 2 diabetes mellitus
- Alternative Name
- Kombiglyze
- Therapeutic Class
- Dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide combination
- Pharmacological Class
- Biguanide, DPP-4 inhibitor
- Minor Side Effects
- nausea, diarrhoea, gastrointestinal distress
- Moderate Side Effects
- urinary tract infection, headache
- Dosage Forms
- Prolonged-release tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Manufacturer
- AstraZeneca
- Onset Time
- 1–2 weeks
- Duration
- Ongoing
- Storage Instructions
- Store below 25°C.
- Drug Interactions
- Alcohol, Cimetidine
- Age Restrictions
- Not for children.